Cargando…
Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting
We appreciate the efforts of the authors in their study on the clinical outcome of hydroxychloroquine (HCQ) therapy in mild coronavirus disease 2019 (COVID-19) (Mokhtari et al., 2021). We would like to make some comments based on our understanding of the study.
Autores principales: | Janapala, Rajesh Naidu, Patel, Jigar, Belfaqeeh, Omar, Pourmand, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206577/ https://www.ncbi.nlm.nih.gov/pubmed/34183274 http://dx.doi.org/10.1016/j.intimp.2021.107878 |
Ejemplares similares
-
Organizational characteristics: Effect on outcome of ICU COVID-19 patients in Belgium
por: Patel, Jigar, et al.
Publicado: (2021) -
Novaferon, treatment in COVID-19 patients
por: Janapala, Rajesh Naidu, et al.
Publicado: (2021) -
Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study
por: Janapala, Rajesh Naidu, et al.
Publicado: (2021) -
Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting
por: Mokhtari, Majid, et al.
Publicado: (2021) -
Azithromycin, a questionable treatment for COVID-19
por: Belfaqeeh, O., et al.
Publicado: (2021)